OTC · Financial Statements
Healios K.K. (HLOSF) Financial Statements
$1.80
OTC: HLOSF
Market Cap $243.00M
Overview Financials Dividend
Healios K.K. most recently reported annual revenue of $104.0M, a net loss of $2.2B. Revenue grew at an average annual rate of 31.0% over the last 5 fiscal years. See the full income statement, balance sheet, and cash flow statement below, plus valuation and return ratios.
Annual Financials (USD)
Metric 2021 2022 2023 2024 2025
Revenue $41.0M $90.0M $121.0M $560.0M $104.0M Operating Profit $-5.4B $-5.2B $-3.4B $-2.8B $-3.4B Net Profit $-4.9B $-5.2B $-3.8B $-4.2B $-2.2B EPS $-93.40 $-90.69 $-56.22 $-47.87 $-20.39 Op Margin -13131.7% -5754.4% -2792.6% -507.7% -3272.1%
Balance Sheet (USD)
Metric 2021 2022 2023 2024 2025
Total Assets $24.0B $15.0B $15.2B $14.2B $17.1B Total Liabilities $15.3B $10.7B $11.3B $12.1B $12.2B Cash $15.1B $7.2B $6.7B $3.7B $5.7B Borrowings $12.0B $7.1B $4.5B $2.7B $2.6B
Cash Flow (USD)
Metric 2021 2022 2023 2024 2025
Operating Cash Flow $-5.1B $-4.6B $-2.8B $-1.8B $-3.2B Investing Cash Flow $-1.0B $-1.2B $-1.1B $-1.7B $-1.3B Financing Cash Flow $229.0M $281.0M $2.8B $328.0M $1.3B Net Cash Flow $1.2B $-7.9B $-525.0M $-3.0B $2.0B Free Cash Flow $-5.4B $-4.9B $-2.9B $-2.1B $-3.3B
Valuation & Return Ratios
Metric Value PEG Ratio -0.36 EV / EBITDA -12.33 FCF Yield -12.13% Quick Ratio 2.05 Interest Coverage -0.91 Return 1Y -47.60% Return 3Y -87.63% Return 5Y —
Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer .